logo UE
ABOUT US

History


Our initial projects focused on analyzing and mapping genetic data, which significantly accelerates biomedical research and the development of new therapies.

History

2018 – we decide to get involved in solving real problems in the healthcare system using the latest technologies.

Since 2018, we have been developing advanced services and products for the medical sector, recognizing that AI is changing the face of healthcare. Our first projects focused on the analysis and mapping of genetic data, which significantly accelerates biomedical research and the development of new therapies.

Genetics at the forefront

Precise genetic data analysis: we have developed advanced methods for fast and accurate comparison of genetic data, allowing the identification of specific genetic variants and mutations.

Clinical trial pipeline: we have developed processes that select candidates for clinical trials based on their genetic profile, increasing the effectiveness and safety of the therapies being tested.

Scientific cooperation and genetic database

In collaboration with a medical university, we have created a database of 675 genetic variants that helps identify and describe mutations. This database supports personalized medicine by enabling treatment to be tailored to individual patients’ needs.

Global recognition

Our team took third place in an international competition for a predictive model that forecasts patient death within three months. This achievement highlights our expertise in AI and bioinformatics and opens up new opportunities for the early identification of high-risk patients. Product development for the healthcare sector.

2023 intensive sales development

We have launched intensive efforts to sell services and products for the medical sector, developing AI systems that support doctors in diagnosing patients. We have established strategic partnerships with key players in the medical and medtech industries and are developing cooperation with numerous hospitals and medical universities.
In collaboration with a medical university, we have created a database of 675 genetic variants that helps identify and describe mutations. This database supports personalized medicine by enabling treatment to be tailored to individual patients’ needs.
Our team took third place in an international competition for a predictive model that forecasts patient death within three months. This achievement highlights our expertise in AI and bioinformatics and opens up new opportunities for the early identification of high-risk patients. Product development for the healthcare sector.
We have launched intensive efforts to sell services and products for the medical sector, developing AI systems that support doctors in diagnosing patients. We have established strategic partnerships with key players in the medical and medtech industries and are developing cooperation with numerous hospitals and medical universities.

Software Solutions segment – 15 years of innovation

We have been implementing IT projects for various sectors for over 15 years. We have completed over 100 projects, supporting clients in the design, creation, and maintenance of IT systems. In the second half of 2023, we signed contracts for IT services worth PLN 34.5 million, continuing our dynamic growth in this segment.
Proacta stands for innovations that change the face of medicine and technology. We are ready for new challenges, creating solutions that have a real impact on the quality of life of patients and the efficiency of IT systems.
# genetyka